Celcuity
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 11 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.4 percentage points.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 118.62% -2.42pp
- Institutions
- 329 -11
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-07-14
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 26 buys · 21 sells
| Name | Role | Stake |
|---|---|---|
| Brian Sullivan | Chairperson & CEO | 6.35% |
| Lance Laing | Co-Founder, Chief Science Officer, VP, Secretary & Director | 2.55% |
| Richard Nigon | Independent Director | 0.16% |
| Vicky Hahne | Chief Financial Officer | 0.04% |
| Leo Furcht | Independent Director | 0.02% |
| Richard Buller | Independent Director | 0.02% |
| Polly Murphy | Independent Director | 0.01% |
| Charles Romp | Independent Director | 0.00% |
| Brightstone Venture Capital | -- | -- |
| David Dalvey | Independent Director | -- |
| David Gryska | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-06 | Leo Furcht | Independent Director | Derivative Exercise and Retained | +250 | $7.60 |
| 2026-09-30 | David Gryska | Independent Director | Other Acquisition | +893 | -- |
| 2026-08-13 | Brian Sullivan | Chairperson & CEO | Other Acquisition | +80,000 | -- |
| 2026-08-13 | Brian Sullivan | Chairperson & CEO | Other Derivative Acquisition | +120,000 | -- |
| 2026-08-13 | Vicky Hahne | Chief Financial Officer | Other Acquisition | +16,000 | -- |
| 2026-08-13 | Vicky Hahne | Chief Financial Officer | Other Derivative Acquisition | +10,000 | -- |
| 2026-08-13 | Lance Laing | Co-Founder, Chief Science Officer, VP, Secretary & Director | Other Acquisition | +20,000 | -- |
| 2026-08-13 | Lance Laing | Co-Founder, Chief Science Officer, VP, Secretary & Director | Other Derivative Acquisition | +10,000 | -- |
| 2026-07-13 | Baker Bros. Advisors LP | -- | Open Market Disposition | -3,100,000 | $102.50 |
| 2026-06-09 | Richard Buller | Independent Director | Other Derivative Acquisition | +12,503 | $10.69 |
| 2026-06-09 | Richard Buller | Independent Director | Other Derivative Disposition | -12,503 | $10.69 |
| 2026-06-09 | Polly Murphy | Independent Director | Other Derivative Acquisition | +14,048 | $10.69 |
| 2026-06-09 | Polly Murphy | Independent Director | Other Derivative Disposition | -14,048 | $10.69 |
| 2026-06-04 | Richard Nigon | Independent Director | Other Acquisition | +1,530 | -- |
| 2026-06-04 | David Dalvey | Independent Director | Other Acquisition | +1,530 | -- |
| 2026-06-04 | Leo Furcht | Independent Director | Other Acquisition | +1,530 | -- |
| 2026-06-04 | Richard Buller | Independent Director | Other Acquisition | +1,530 | -- |
| 2026-06-04 | Charles Romp | Independent Director | Other Acquisition | +1,530 | -- |
| 2026-06-04 | Polly Murphy | Independent Director | Other Acquisition | +1,530 | -- |
| 2026-06-01 | Lance Laing | Co-Founder, Chief Science Officer, VP, Secretary & Director | Derivative Exercise and Retained | +1,000 | $9.89 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.
Celcuity discussion 0 comments